Scientists track new Drug's journey through body and brain
NCT ID NCT02362516
Summary
This early-stage study aimed to understand how a new drug called BI 425809 moves through the body and into the brain's spinal fluid. It involved 25 healthy male volunteers who took different oral doses. Researchers measured drug levels in blood and spinal fluid over time to check safety and see how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1346.3.32001 Boehringer Ingelheim Investigational Site
Antwerp, Belgium
Conditions
Explore the condition pages connected to this study.